ARTICLE SUMMARY:
Though broad in scope and widely used, targeted temperature management technologies can sometimes be overlooked by investors because the space has been dominated by low-tech products. But greater nuance and expanded applications continue to drive development and investment in unserved product areas. Now, COVID-19 represents a possible boom in relevance for TTM, as both warming and cooling methods can benefit patients at various stages of treatment.
Core body temperature is one of four classically-recognized vital signs in both healthy and sick patients, and its regulation is crucial to overall well-being and proper bodily function. Since the time of Hippocrates, who would place cold mud on wounded soldiers in the battlefield to extend their chances of survival or recovery, therapeutic cooling (otherwise known as therapeutic hypothermia) has been known to combat ischemic tissue damage, bacterial infection, and other complications resulting from illness, injury, or surgery.
